0001209191-20-008815.txt : 20200212 0001209191-20-008815.hdr.sgml : 20200212 20200212165350 ACCESSION NUMBER: 0001209191-20-008815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200205 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandercock Colin CENTRAL INDEX KEY: 0001724870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 20605011 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-05 0 0001645460 Cue Biopharma, Inc. CUE 0001724870 Sandercock Colin 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 SVP, General Counsel and Sec Stock Option (right to buy) 16.26 2020-02-05 4 A 0 20000 0.00 A 2030-02-05 Common Stock 20000 20000 D This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 5, 2020. /s/ Colin Sandercock by Mark Busch, as attorney-in-fact 2020-02-12